HBIO

Harvard Biosci

• TipRanks·06/16 19:35

  Harvard Bioscience management to meet with KeyBanc

• TipRanks·06/02 21:51

  Harvard Bioscience Shareholders Expand Equity Plans, Elect Directors

• PUBT·06/02 20:02

  Harvard Bioscience shareholders approve amended 2021 incentive plan share increase at annual meeting

• Benzinga·05/29 20:09

  Lensar Appoints Michael A. Rossi As Interim CFO Effective May 29, 2026

• PUBT·05/29 20:07

  LENSAR names Michael Rossi interim CFO effective May 29

• TipRanks·05/20 02:06

  Harvard Bioscience Balances Margin Gains With Soft Sales

• TipRanks·05/13 00:23

  Harvard Bioscience Earnings Call Highlights Gradual Recovery

• TipRanks·05/12 14:05

  Harvard Bioscience reports Q1 adjusted EPS (33c) vs. ($1.25) last year

• TipRanks·05/12 13:59

  Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M

• TipRanks·05/12 13:45

  Harvard Bioscience reaffirms FY26 revenue growth of 2%-4%

• Seeking Alpha·05/12 13:33

  Harvard Bioscience reaffirms 2026 outlook for 2%-4% revenue growth as Project Viking targets $4M annual savings

• TipRanks·05/12 12:44

  Harvard Bioscience Unveils Strategic Transformation Toward Translational Tools

• Benzinga·05/12 12:38

  Harvard Bioscience Q1 2026 Earnings Call Transcript

• Reuters·05/12 11:40

  Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance

• Seeking Alpha·05/12 11:38

  Harvard Bioscience misses top-line and bottom-line estimates; initiates Q2 and reaffirms FY26 outlook